{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-075697","form_type":"8-K","ticker":"RIGL","cik":"0001034842","company_name":"RIGEL PHARMACEUTICALS INC","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.956229+00:00","generated_at":"2026-06-01T00:55:13.056301+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Rigel Pharmaceuticals effects 1-for-10 reverse stock split effective June 27, 2024","bullets":["Board approved 1-for-10 reverse split on June 15; effective June 27 at 12:01 a.m. ET.","Common stock now trades under new CUSIP 766559702.","No fractional shares issued; cash paid for fractions based on prior-day closing price.","Stockholders authorized a split ratio range of 1:2 to 1:20 at May 24, 2024 annual meeting.","Amendment to certificate of incorporation filed with Delaware Secretary of State."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-075697","json":"https://secwatch.observer/filing/0001104659-24-075697.json","markdown":"https://secwatch.observer/filing/0001104659-24-075697.md","text":"https://secwatch.observer/filing/0001104659-24-075697.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1034842/000110465924075697/0001104659-24-075697-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1034842/000110465924075697/tm2417992d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:55:13.056301+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}